smartbax GmbH
PrivateLast Round
pre_series_a
Oct 22, 2025
Total Funding Raised
$1.3M
Momentum Score
25 /100
Company Overview
smartbax GmbH is a biotechnology company that develops a new generation of antibiotics to address the increasing spread of multidrug-resistant bacteria.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
smartbax GmbH Comps
Public and private peers based on sector, stage, and business model.
smartbax GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| pre_series_a | Oct 22, 2025 | ||||
| Seed | May 23, 2023 |
smartbax GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim Venture Fund | Seed |
| UnternehmerTUM Funding for Innovators | pre_series_a |
| Boehringer Ingelheim Venture Fund | pre_series_a, Seed |
| Bayern Kapital | pre_series_a |
| High-Tech Gründerfonds | pre_series_a, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
$5M raised in pre-Series A round.
smartbax GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about smartbax GmbH's valuation, stock price, and market status.
